Glaxo Smithkline Consumer Nigeria PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smithkline Consumer Nigeria PLC with three other
pharmaceutical manufacturers in Africa:
Societe Adwya SA
sales of 95.34 million Dinar [US$31.08 million]
of which 57%
Fidson Healthcare Limited
(14.06 billion Naira [US$45.97 million]
based in Morocco
(511.20 million Moroccan Dirhams [US$53.53 million]
During the year ended December of 2017, sales at
Glaxo Smithkline Consumer Nigeria PLC were 16.09 billion Naira (US$52.61 million).
increase of 11.9%
versus 2016, when the company's sales were 14.38 billion Naira.
Despite this increase, sales are still
below the level achieved in 2015, when Glaxo Smithkline Consumer Nigeria PLC
reported sales of 30.63 billion Naira.
Sales of Pharmaceuticals saw an increase
13.6% in 2017, from
9.12 billion Naira to 10.36 billion Naira.